top of page

Investors

Our Journey

May 2015 

Company founded in Malaysia

July 2015

Successfully awarded seed grant of USD150,000 by Malaysian government agency, Platcom Ventures

August 2015

Selected by Malaysia Global Innovation & Creativity Centre (MaGIC) for e@Stanford USA Program Batch 2015

November 2018

Launching of biosensor platform for molecular diagnostics

May 2019

Launching of in silico platform for design and validation of oligo-based synthetic antibodies (aptamers)

July 2019

Participated in NextRise 2019 Korea for pitching to regional investors

For more detailed information, please email contact@biogenestech.com

bottom of page